Hyloris Pharmaceuticals SA (EBR: HYL)

Hyloris Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	29.77	29.77	41.76	89.44	6.38	15.13
Short-Term Investments	-	-	20	-	-	-
Cash & Short-Term Investments	29.77	29.77	61.76	89.44	6.38	15.13
Cash Growth	-51.80%	-51.80%	-30.95%	1301.49%	-57.82%	74.60%
Other Receivables	0.41	0.41	1.23	1.3	0.15	0.18
Receivables	0.41	0.41	1.23	1.3	0.15	0.18
Restricted Cash	-	-	-	-	0.02	0.01
Other Current Assets	1.24	1.24	1.19	1.64	0.42	0.17
Total Current Assets	31.42	31.42	64.18	92.39	6.97	15.49
Property, Plant & Equipment	2.09	2.09	2.1	2.38	0.4	0.47
Goodwill	1.85	1.85	1.9	1.7	1.61	1.73
Other Intangible Assets	7.96	7.96	8.26	8.33	5.22	5.65
Long-Term Deferred Tax Assets	0.31	0.31	0.16	-	-	-
Total Assets	43.63	43.63	76.59	104.8	14.19	23.35
Accounts Payable	1.37	1.37	1.91	0.95	0.91	1.31
Accrued Expenses	1.73	1.73	2.32	1.9	1.21	0.68
Current Portion of Leases	0.57	0.57	0.43	0.47	0.14	0.13
Current Income Taxes Payable	0.22	0.22	0.22	0.08	0.03	0.04
Current Unearned Revenue	1.83	1.83	1.33	-	0.1	0.22
Other Current Liabilities	0.96	0.96	2.02	2.14	0.28	0.34
Total Current Liabilities	6.68	6.68	8.22	5.54	2.67	2.71
Long-Term Debt	15.26	15.26	12.66	11.45	41.82	33.48
Long-Term Leases	1.05	1.05	1.29	1.74	0.06	0.2
Long-Term Deferred Tax Liabilities	0.63	0.63	0.67	1.99	1.34	1.45
Total Liabilities	25.7	25.7	23.96	22.11	46.29	38.27
Common Stock	3.62	3.62	3.62	3.62	-	-
Additional Paid-In Capital	155.25	155.25	155.25	155.25	3.08	3.08
Retained Earnings	-145.43	-145.43	-108.32	-75.97	-53.11	-32.92
Comprensive Income & Other	4.49	4.49	2.08	-0.21	3.14	0.67
Total Common Equity	17.93	17.93	52.63	82.68	-46.89	-29.17
Shareholders' Equity	17.93	17.93	52.63	82.68	-32.1	-14.92
Total Liabilities & Equity	43.63	43.63	76.59	104.8	14.19	23.35
Total Debt	16.87	16.87	14.38	13.67	42.02	33.8
Net Cash (Debt)	12.89	12.89	47.38	75.78	-35.63	-18.67
Net Cash Growth	-72.79%	-72.79%	-37.47%	-	-	-
Net Cash Per Share	0.43	0.43	1.57	7.99	-9.90	-6.19
Filing Date Shares Outstanding	30.18	30.18	30.18	30.18	9.58	3.02
Total Common Shares Outstanding	30.18	30.18	30.18	30.18	9.58	3.02
Working Capital	24.74	24.74	55.96	86.85	4.3	12.78
Book Value Per Share	0.59	0.59	1.74	2.74	-4.89	-9.67
Tangible Book Value	8.13	8.13	42.47	72.65	-53.71	-36.55
Tangible Book Value Per Share	0.27	0.27	1.41	2.41	-5.61	-12.11
Machinery	1.28	1.28	0.92	0.8	0.71	0.54
Leasehold Improvements	0.34	0.34	0.27	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.